CVE-2018-10599
IntelliVue Patient Monitors MP Series (including MP2/X2/MP30/MP50/MP70/NP90/MX700/800) Rev B-M,...
IntelliVue Patient Monitors MP Series (including MP2/X2/MP30/MP50/MP70/NP90/MX700/800) Rev B-M, IntelliVue Patient Monitors MX (MX400-550) Rev J-M and (X3/MX100 for Rev M only), and Avalon Fetal/Maternal Monitors FM20/FM30/FM40/FM50 with software Revisions F.0, G.0 and J.3 have a vulnerability that allows an unauthenticated attacker to read memory from an attacker-chosen device address within the same subnet.
Attack profile
How easy it is to exploit
- Attack vector
- Adjacent network
- Complexity
- High
- Privileges needed
- None
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- None
- Availability
- None
Exploit likelihood
What each source reports
NVD Score used
IntelliVue Patient Monitors MP Series (including MP2/X2/MP30/MP50/MP70/NP90/MX700/800) Rev B-M, IntelliVue Patient Monitors MX (MX400-550) Rev J-M and (X3/MX100 for Rev M only), and Avalon Fetal/Maternal Monitors FM20/FM30/FM40/FM50 with software Revisions F.0, G.0 and J.3 have a vulnerability that allows an unauthenticated attacker to read memory from an attacker-chosen device address within the same subnet.
- Record
CVE-2018-10599- CVSS 3.0
- 5.3 Medium
CVSS:3.0/AV:A/AC:H/PR:N/UI:N/S:U/C:H/I:N/A:N - CVSS 2.0
- 2.9 Low
AV:A/AC:M/Au:N/C:P/I:N/A:N - Weakness
- CWE-200
- Updated
- 2026-11-02
CVE List No score
IntelliVue Patient Monitors MP Series (including MP2/X2/MP30/MP50/MP70/NP90/MX700/800) Rev B-M, IntelliVue Patient Monitors MX (MX400-550) Rev J-M and (X3/MX100 for Rev M only), and Avalon Fetal/Maternal Monitors FM20/FM30/FM40/FM50 with software Revisions F.0, G.0 and J.3 have a vulnerability that allows an unauthenticated attacker to read memory from an attacker-chosen device address within the same subnet.
- Record
CVE-2018-10599- Weakness
- CWE-200
- Updated
- 2026-11-02
EUVDEUVD-2018-2671 No score
IntelliVue Patient Monitors MP Series (including MP2/X2/MP30/MP50/MP70/NP90/MX700/800) Rev B-M, IntelliVue Patient Monitors MX (MX400-550) Rev J-M and (X3/MX100 for Rev M only), and Avalon Fetal/Maternal Monitors FM20/FM30/FM40/FM50 with software Revisions F.0, G.0 and J.3 have a vulnerability that allows an unauthenticated attacker to read memory from an attacker-chosen device address within the same subnet.
- Record
EUVD-2018-2671- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-36x7-j8mh-46ff
IntelliVue Patient Monitors MP Series (including MP2/X2/MP30/MP50/MP70/NP90/MX700/800) Rev B-M,...
IntelliVue Patient Monitors MP Series (including MP2/X2/MP30/MP50/MP70/NP90/MX700/800) Rev B-M, IntelliVue Patient Monitors MX (MX400-550) Rev J-M and (X3/MX100 for Rev M only), and Avalon Fetal/Maternal Monitors FM20/FM30/FM40/FM50 with software Revisions F.0, G.0 and J.3 have a vulnerability that allows an unauthenticated attacker to read memory from an attacker-chosen device address within the same subnet.
- Record
GHSA-36x7-j8mh-46ff- CVSS 3.0
- 5.3 Medium
CVSS:3.0/AV:A/AC:H/PR:N/UI:N/S:U/C:H/I:N/A:N - Weakness
- CWE-200
- Updated
- 2026-11-02
Affected products
- ics-cert intellivue patient monitors, avalon fetal/maternal monitors
- philips avalon fetal\/maternal monitors fm20 firmware
- philips avalon fetal\/maternal monitors fm30 firmware
- philips avalon fetal\/maternal monitors fm40 firmware
- philips avalon fetal\/maternal monitors fm50 firmware
- philips intellivue mp2 firmware
- philips intellivue mp30 firmware
- philips intellivue mp50 firmware
- philips intellivue mp70 firmware
- philips intellivue mx100 firmware
- philips intellivue mx400 firmware
- philips intellivue mx450 firmware
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2018-10599 is a medium vulnerability (CVSS 5.3) in Ics-cert Intellivue Patient Monitors, Avalon Fetal/maternal Monitors, published June 5, 2018. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.42%, the 36th percentile. No source names a fixed version.